Login
Toggle navigation
Videos
Categories
Trending
Tal Yalon, M.D., Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Thyroid & Parathyroid Surgery: Ask Mayo Clinic Health System
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Mastering Purposeful Curiosity: Transforming Questions into Solutions with Professor Costas Andreou|Costas Andriopoulos,Professor,Bayes Business School
00:10:00
Managing Transmission Investments and Climate Resilience | Rui Chammas, CEO, CTEEP Companhia de Transmissao de Energia Eletrica Paulista.
00:10:00
They invest and support founders from seed until the later stages success|Teddie Wardi,Managing Director,Insight Partners
00:10:00
Mutares CIO Johannes Laumann Discusses Acquisition Strategy and Turnaround Initiatives | Johannes Laumann , CIO, Mutares.
00:10:00
David Bramhill on Union Jack Oil's Financial Surge and Future Outlook | David Bramhill, Executive Chairman, Union Jack Oil Plc.
00:10:00
Advancements in Biocompatible Artificial Heart Technology and Future Prospects | Stéphane Piat, CEO, Carmat SA.
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.
00:10:00
The Art of Storytelling with Aoifinn Devitt, CIO of the Moneta Group
00:10:00
Exploring a Striking Convergence Between Islamic Revelation and Modern Biblical Scholarship|Dr Graham Stanton,Cambridge University
00:10:00
How To Build A Successful Financial Planning Business From Scratch | Kyle Moore - FOUNDER, FINANCIAL PLANNER of Quarry Hill Advisors
00:10:00
Dundee Sustainable Technologies: Innovating Cyanide-Free Gold Recovery and Arsenic Stabilization
00:10:00
Global Infrastructure Investment Company Shares Strategy and Market Insights | Jason Boyes, CEO, Infratil Ltd.